HEALTHSTREAM INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
HSTM$28.89-2.4%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $59,469 | $40,333 |
| Marketable securities | 37,748 | 30,800 |
| Accounts receivable, net | 30,189 | 34,346 |
| Accounts receivable - unbilled | 5,133 | 4,100 |
| Prepaid royalties, net of amortization | 9,547 | 10,202 |
| Prepaid software maintenance and subscriptions | 8,569 | 7,397 |
| Other prepaid expenses and other current assets | 2,467 | 3,032 |
| Total current assets | 153,122 | 130,210 |
| Property and equipment, net | 10,741 | 13,005 |
| Capitalized software development, net | 43,370 | 40,643 |
| Operating lease right of use assets, net | 17,453 | 20,114 |
| Goodwill | 191,220 | 191,379 |
| Intangibles, net | 55,548 | 68,031 |
| Other assets | 39,312 | 36,560 |
| Total assets | $510,766 | $499,942 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $6,628 | $7,465 |
| Accrued royalties | 5,190 | 4,556 |
| Accrued liabilities | 10,141 | 13,225 |
| Accrued compensation | 9,507 | 9,492 |
| Deferred revenue | 84,227 | 83,623 |
| Total current liabilities | 115,693 | 118,361 |
| Deferred tax liabilities | 14,596 | 16,132 |
| Deferred revenue, noncurrent | 1,655 | 2,169 |
| Operating lease liability, noncurrent | 17,366 | 20,247 |
| Other long-term liabilities | 2,101 | 2,281 |
| Commitments and contingencies | ||
| Shareholders’ equity: | ||
| Preferred stock, no par value, 10,000 shares authorized, no shares issued or outstanding | — | — |
| Common stock, no par value, 75,000 shares authorized; 30,432 and 30,298 shares issued and outstanding at December 31, 2024 and 2023, respectively | 252,432 | 249,075 |
| Retained earnings | 108,972 | 92,368 |
| Accumulated other comprehensive loss | (2,049) | (691) |
| Total shareholders’ equity | 359,355 | 340,752 |
| Total liabilities and shareholders’ equity | $510,766 | $499,942 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.